Orbimed Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$23.3 - $59.57 $5.9 Million - $15.1 Million	-253,108 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $2.65 Million - $3.7 Million	-129,292 Reduced 33.81%	253,108 $5.79 Million
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $5.09 Million - $8.65 Million	382,400 New	382,400 $8 Million
Q4 2018 Feb 14, 2019	SELL	$11.21 - $23.53 $8.69 Million - $18.2 Million	-775,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $9.05 Million - $14.9 Million	775,000 New	775,000 $14.5 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.